April 27 @ 4:30 pm – 6:30 pm EDT – FREE
Heart disease remains the number one killer of men and women in the US and globally. Unexpectedly, COVID-19 has emerged as a major new cause of cardiac damage. In this Forum, you will hear from leaders in interventional cardiology who are developing technologies to overcome challenges in treating cardiovascular patients. These include imaging, drug delivery, biomarkers for COVID-19 related clot formation, and structural heart disease. Hear and meet these leaders in CV disease diagnosis and treatment.
Dr. Albaghdadi is an accomplished physician-scientist with a background in engineering and pre-clinical testing, and device innovation. He has developed many cardiovascular technologies including intravascular imaging modalities, macro- and nano-drug delivery systems, biomarkers in COVID19-related thrombosis, and structural heart disease.
Dr. Higano is Medical Director of Heart LifeLine Alliance, formed in 2008 in partnership with rural hospitals, medical helicopter and ambulance services to provide emergency services for rapid evaluation and treatment of heart attack patients. He will speak about how new technologies are helping to overcome challenges in interventional cardiology.
Ms. Sundararaman is a recent graduate of Northeastern University with a Master’s Degree in Bioengineering with a specialization in medical device design and bio-imaging.
Lisa Sasso, MBA, PCC, CPCC
Executive Coach & President, Medical Development Partners; Former President, MDG Boston MODERATOR
Ms. Sasso was President & CEO of Radi Medical Systems for 6 years. She grew revenue from $0 to $28M and was recognized and ranked #28 out of 100 Women Led Businesses in MA in 2004. She is President of Medical Development Partners and offers her experiences as an executive coach.
- 4:30 – 5:00 General Networking
- 5:00 – 6:00 Panelist Forum
- 6:00 – 6:30+ Meet the Speakers & More Networking
All Zoom links for the Forum and Networking sessions will be sent upon registration and again just prior to the event.